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The BM is the preferred site for adult hemato-
poiesis. Transplantation of BM cells containing 
hematopoietic stem cells (HSCs) and progeni-
tors has been a remarkable medical advance-
ment  that  allows  for  the  replacement of  the 
hematopoietic  compartment  after  preparative 
regimens.  HSCs  are  retained  in  perivascular 
niches that are distributed near osteoblasts and 
within the nonendosteal parenchyma (Kiel et al., 
2005; Sugiyama et al., 2006; Lo Celso et al., 
2009; Méndez-Ferrer et al., 2010b).  The ability 
to mobilize HSCs/progenitors out of the BM 
into the peripheral blood has allowed for effi-
cient, less invasive HSC procurement in clinical 
stem cell transplantation. However, up to 30% 
of  patients  previously  treated  with  cytotoxic 
anticancer therapies do not mobilize sufficient 
numbers of stem cells using current protocols 
(Bensinger et al., 2009).
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Hematopoietic stem cells (HSCs) reside in specialized bone marrow (BM) niches regulated 
by the sympathetic nervous system (SNS). Here, we have examined whether mononuclear 
phagocytes modulate the HSC niche. We defined three populations of BM mononuclear 
phagocytes that include Gr-1hi monocytes (MOs), Gr-1lo MOs, and macrophages (M) 
based on differential expression of Gr-1, CD115, F4/80, and CD169. Using MO and M 
conditional depletion models, we found that reductions in BM mononuclear phagocytes led 
to reduced BM CXCL12 levels, the selective down-regulation of HSC retention genes in 
Nestin+ niche cells, and egress of HSCs/progenitors to the bloodstream. Furthermore, spe-
cific depletion of CD169+ M, which spares BM MOs, was sufficient to induce HSC/ 
progenitor egress. M depletion also enhanced mobilization induced by a CXCR4 antago-
nist or granulocyte colony-stimulating factor. These results highlight two antagonistic, 
tightly balanced pathways that regulate maintenance of HSCs/progenitors in the niche 
during homeostasis, in which M cross talk with the Nestin+ niche cell promotes retention, 
and in contrast, SNS signals enhance egress. Thus, strategies that target BM M hold the 
potential to augment stem cell yields in patients that mobilize HSCs/progenitors poorly.
© 2010 Chow et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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population were positive for F4/80 (Fig. S1 A), CD11c, and 
MHC class II (Fig. 1 C).
The Gr-1–CD115intF4/80+ fraction consisted of two 
populations: eosinophils (Fig. 1 A, gate V) and a population of 
mononuclear cells (gate IV), which could be discriminated by 
forward and side scatter characteristics. The Gr-1– CD115int 
F4/80+ subset, after exclusion of SSChi eosinophils, comprised 
2.6 ± 0.2% of BM cells and was the only population of BM 
mononuclear phagocytes that showed expression of CD169 
(Fig. 1 C). CD169, also known as sialoadhesin or SIGLEC-1, 
is a sialic acid binding molecule that was initially described 
over two decades ago to have high activity on BM stromal 
and lymph node M, but not on blood MO (Crocker and 
Gordon, 1986). CD169 is recognized by the M antibody 
MOMA-1, which has long been used to stain M in the 
spleen, lymph nodes, lamina propria, Peyer’s patches, and CNS 
(Oetke et al., 2006). Based on this marker, we will subsequently 
call this cell population BM M. These Gr-1– CD115int 
F4/80+ CD169+ M also expressed intermediate levels of 
MHC class II, CD11c, and CD68; low expression of CD11b; 
and negligible expression of CX3CR1 (Fig. 1 C).
Depletion of BM mononuclear phagocytes correlates with 
HSC/progenitor egress and reduction in marrow CXCL12
We first depleted BM MO/M using clodronate liposome 
injection. 14 h after clodronate liposome administration, BM 
M were reduced by 84% (Fig. 2, A and B), whereas Gr-1hi 
MO, Gr-1lo MO, and total BM cellularity were reduced by 79, 
88, and 24%, respectively, compared with PBS-treated animals 
(Fig. 2, A and C–E). Depletion of the noneosinophil Gr-1– 
CD115+ F4/80+ population with clodronate further supports 
the conclusion that these CD169+ cells are indeed M.   
We assessed the effect of BM MO/M depletion on cir-
culating hematopoietic progenitors and found a marked in-
crease in colony-forming unit activity (4.5-fold; Fig. 2 F) and 
Lineage–Sca-1+c-kit+ (LSK) cells (6.2-fold; Fig. 2 G) in blood 
after mononuclear phagocyte depletion. Notably, circulating 
LSK Flk2– cells, enriched in long-term repopulating HSCs 
(Christensen and Weissman, 2001), increased by 12.9-fold   
after clodronate treatment (Fig. 2 H).
We next determined the effect of mononuclear phago-
cyte depletion in modulating the levels of CXCL12, a che-
mokine produced by stromal niche cells that is crucial in 
retention and maintenance of HSCs/progenitors in the BM 
(Méndez-Ferrer and Frenette, 2007). Clodronate-induced de-
pletion of BM MO/M and HSC/progenitor mobilization 
was associated with a 44% reduction in CXCL12 mRNA 
levels in total BM (Fig. 2 I) and a 40% reduction in CXCL12 
protein in the BM extracellular fluid (BMEF; Fig. 2 J). Because 
BM MO/M do not produce CXCL12 (Fig. S2), these data 
suggest that MO/M depletion causes a reduction in CXCL12 
expression by BM stromal cells.
These results were further confirmed using other con-
ditional depletion models of mononuclear phagocytes, in-
cluding transgenic mice expressing the diphtheria toxin 
(DT) receptor under the CD11b promoter (CD11b-DTR;   
Sympathetic neural tone is crucial for both steady state 
(Méndez-Ferrer  et  al.,  2008)  and  granulocyte  colony- 
stimulating factor (G-CSF)–enforced (Katayama et al., 2006) 
release of HSCs/progenitors from the BM. Recent studies 
indicate that mesenchymal stem cells (MSCs), identified by 
the expression of the intermediate filament protein Nestin, 
comprise a critical cellular constituent of the stem cell niche 
that is under the control of the sympathetic nervous system 
(SNS; Méndez-Ferrer et al., 2010b). Because previous studies 
using G-CSF receptor–deficient mice showed that expression 
of the receptor on transplantable hematopoietic cells was re-
quired for G-CSF–induced mobilization (Liu et al., 2000), we 
have previously speculated that at least two distinct pathways, 
neural and hematopoietic, acted in concert to promote HSC/
progenitor egress (Katayama et al., 2006).
Hypothesizing that mononuclear phagocytes are crucial 
for stromal function of the BM, we sought to eliminate these 
populations to evaluate their contributions to HSC trafficking. 
Unexpectedly, we have found that BM macrophages (M) 
did not promote the egress of HSCs/progenitors, but rather 
contributed to the retention of HSCs in the BM by acting on 
Nestin+ MSCs. These data uncover a new role for the innate 
immune system in regulating stem cell niche functions.
RESULTS
Phenotypic markers of BM mononuclear phagocytes
Depletion of monocytes (MO) and/or M from the BM has 
been accomplished with injection of clodronate liposomes 
(Giuliani et al., 2001) and injection of the FK-binding pro-
tein dimerizer AP20187 in transgenic Mafia mice (Burnett et al., 
2004; Chang et al., 2008). Mafia mice have a Fas suicide/ 
apoptotic system driven by the CD115 (M-CSF receptor) pro-
moter. Previous phenotypic descriptions of BM M have 
exclusively relied on F4/80 expression (Hume et al., 1983; 
Giuliani et al., 2001; Chang et al., 2008). However, this marker 
is also expressed on BM neutrophils (Gr-1+CD115), Gr-1hi 
MO (Gr-1+CD115+), Gr-1lo MO (Gr-1CD115+; Gordon 
and Taylor,  2005),  and  eosinophils  (SSChiSiglec-F+;  Zhang   
et al., 2004; Fig. S1). To distinguish among BM mononuclear 
phagocytes and to elucidate their differential surface pheno-
types, we purified different BM populations via cell sorting 
based on three markers: Gr-1 (Ly6C/G), CD115, and F4/80. 
As expected, neutrophil granulocytes were homogenously 
represented in the Gr-1+CD115 gate (Fig. 1 A, gate I) and 
represented 49.6 ± 1.1% of the total BM nucleated cells.   
In mice, there are two subsets of CD115+ MO that differen-
tially express Gr-1 (Gordon and  Taylor, 2005).  In concordance, 
the Gr-1+CD115+ portion (Fig. 1 A, gate II) represented a   
homogenous population of MO (Fig. 1 B) that constituted   
9.8  ±  0.3%  of  the  BM  and  is  characterized  as  F4/80hi 
CD11bhi  CD68int  CX3CR1int  MHCII–  CD11c–  CD169– 
(Fig. 1 C and Fig. S1 A), and will herein be termed Gr-1hi 
MO. The Gr-1–CD115+ population (Fig. 1 A, gate III) rep-
resenting 1.4 ± 0.1% of BM consisted of a population of 
MO (Fig. 1 B) characterized as CX3CR1hi CD11bint CD68int  
CD169– and will be termed Gr-1lo MO. Subsets of this   JEM VOL. 208, February 14, 2011 
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47%  reduction  in  BMEF  CXCL12 
(Fig. S3 S). These data are consistent 
with a recent study also using liposo-
mal clodronate and Mafia mice that 
demonstrated the association of BM 
mononuclear phagocyte depletion with 
HSC/progenitor egress (Winkler et al., 
2010). Progenitor release cannot be 
explained by nonspecific cell death be-
cause in vivo depletion of neutrophils 
and Gr-1hi MO using anti–Gr-1 (Ly6G/
C) antibody or depletion of dendritic 
cells  using  DT  administration  in 
CD11c-DTR mice (Jung et al., 2002) 
did not lead to any progenitor mobiliza-
tion (unpublished data). Collectively, these results suggest   
that mononuclear phagocytes play a critical role in the reten-
tion of HSCs/progenitors in the BM.
Mononuclear phagocytes regulate Nestin+ niche cells that 
maintain HSCs in the BM
Recent studies have revealed that GFP expression, when 
driven by Nestin regulatory elements, identifies rare MSCs 
that form HSC niches (Méndez-Ferrer et al., 2010b). We ob-
served CD68+ and CD169+ cells throughout the BM and in 
the vicinity of rare Nestin+ MSC niche cells (Fig. 3 A). To evalu-
ate whether mononuclear phagocytes regulate Nestin+ niche 
cells, we used clodronate liposomes to deplete BM MO/M. 
Because the number of Nestin+ cells was unchanged by this 
treatment (Fig. S4 D), we assessed alterations in gene expres-
sion in these cells. We sorted CD45 Ter119 Nestin+ and 
CD45 Ter119 Nestin from the BM and CD45 Ter119 
CD31  Sca-1  CD51+  osteoblasts  (Semerad  et  al.,  2005; 
Winkler et al., 2010) from the bone 14 h or 7 d after depletion 
(Fig.  S4, A  and  B).  Bone  CD45 Ter119  CD31  Sca-1  
CD51+ cells were confirmed to be enriched in osteoblasts by 
Figure 1.  Mononuclear phagocytes can 
be distinguished in the BM with Gr-1, 
CD115, and F4/80. (A) Gating strategy of 
BM mononuclear phagocytes. The Gr-1+ pop-
ulations were divided into a CD115 fraction 
comprised of neutrophils (I; left) and CD115+ 
fraction of Gr-1hi MOs (II; left). The Gr-1lo 
fraction was further subdivided into two pop-
ulations (middle): CD115+ Gr-1lo MOs (III) and 
a F4/80+CD115int population, which can be 
subdivided into SSChi eosinophils (V) and  
SSCint/lo M (IV). (B) Morphology of cell popula-
tions I–IV (63× magnification; bars, 10 µm). 
(C) Overlay histograms show the differential 
expression of CD11b, CD11c, MHC class II, 
CX3CR1, CD68, and CD169 (blue line) among 
mononuclear phagocyte populations.  
Gray histograms represent isotype control.  
All results are representative of two indepen-
dent experiments.
Cailhier et al., 2005) and the Mafia mice (Burnett et al., 2004). 
In these studies, we generated BM chimeric mice in which 
wild-type recipients were reconstituted with BM cells iso-
lated from these transgenic animals to minimize toxicity of 
the depleting agents to nonhematopoietic organs. Treatment 
of CD11b-DTR chimeric animals with DT reduced BM 
M counts by >40% (Fig. S3 A) and MO subsets by >50% 
(Fig. S3, B and C). Consistent with the expression of CD11b, 
also  on  neutrophils,  total  BM  cellularity  was  reduced  by 
40% in this model (Fig. S3 D). Concomitantly, progenitors 
circulating in blood were significantly increased by 1.6-fold 
(Fig. S3 E) and BMEF CXCL12 was significantly reduced 
(Fig. S3 F). AP20187-treated Mafia BM chimeras depleted 
BM M, MO, and total BM cells by 40, >80, and 30%, re-
spectively (Fig. S3, G–J). This was associated with an 6-fold 
increase in circulating progenitors (Fig. S3 K), and 46% re-
duction in BM CXCL12 levels (Fig. S3 L). In nontransplanted 
Mafia mice, mobilization was even more robust; AP20187-
treated Mafia animals exhibited a >80% reduction in MO/
M (Fig. S3, M–P), 31% reduction in BM cellularity (Fig. S3 Q), 
>20-fold increase in circulating progenitors (Fig. S3R), and 264 Bone marrow macrophages promote HSC retention | Chow et al.
controls (Fig. S4, D–G).  These results, together 
with the gene expression analyses (Fig. 3, B–E; 
and Fig. S5), suggest that BM mononuclear 
phagocytes  play  a  role  in  HSC/progenitor   
retention by regulating maintenance of reten-
tion  gene  expression  specifically  in  Nestin+ 
niche cells, but not osteoblasts.
Microarray expression analyses have shown 
that Nestin+ cells express high levels of Csf1 
(Méndez-Ferrer et al., 2010b), a critical cytokine 
for M development and survival (Hamilton, 
2008). To determine whether Nestin+ cells in 
the BM regulate mononuclear phagocyte num-
bers, we depleted Nestin+ cells by administering 
DT into tamoxifen-treated Nes-CreERT2/iDTR  
animals (Méndez-Ferrer et al., 2010b). We found no dif-
ference in BM M (Fig. S6 A) or MO (Fig. S6, B and C) in 
Nes-CreERT2/iDTR mice treated with tamoxifen and DT, 
compared with control iDTR animals.
BM M produce a protein factor that raises CXCL12 
production by stromal cells in vitro
The aforementioned results demonstrate a robust in vivo cor-
relation between BM MO/M depletion, CXCL12 reduc-
tion, and HSC/progenitor mobilization. To further dissect the 
effect of mononuclear phagocytes on stromal cell function, 
we established long-term murine Dexter BM cultures con-
sisting of an adherent stromal layer and attached hematopoi-
etic cells (Dexter et al., 1977). Consistent with the in vivo 
data, we found that clodronate liposome treatment of Dexter 
cultures dramatically reduced the cellularity in the wells,   
especially among the adherent M, compared with PBS   
liposome-treated wells (Fig. 4 A). The number of CD115+ 
mononuclear  phagocytes  was  indeed  reduced  by  >50%   
after liposomal clodronate treatment (Fig. 4 B). These changes 
in  mononuclear phagocytes were associated with decreased 
stromal production of CXCL12 at 24 h (30%↓) and 72 h 
(40%↓; Fig. 4 C).
high  Osteocalcin  expression  compared  with  CD45 Ter119 
CD31+ endothelial cells (Fig. S4 C). From these populations, we 
performed quantitative real-time PCR (Q-PCR) of genes en-
coding molecules previously implicated in HSC maintenance 
and retention (Cxcl12, Angpt1, Kitl, and Vcam1).  These genes 
are highly expressed by Nestin+ cells and down-regulated 
during G-CSF–induced mobilization or upon 3 adrenergic 
signaling (Méndez-Ferrer et al., 2010b). As previously reported, 
Nestin+ cells from the BM had markedly higher expression   
of the four retention genes, compared with the Nestin frac-
tion (Méndez-Ferrer et al., 2010b). Interestingly, we found 
that the expression of Cxcl12, Angpt1, Kitl, and Vcam1 was 
48-, 18-, 65-, and 35-fold higher, respectively, in Nestin+ cells 
in the BM compared with bone osteoblasts in the steady state 
(Fig. 3, B–E). Strikingly, we observed a 65–80% reduction in 
the expression of these four genes 14 h after treatment with 
clodronate, compared with PBS liposome-treated animals 
(Fig. 3, B–E). The reduced expression persisted at least until 
day 7 after treatment with clodronate (Fig. S5). In contrast, 
the expression levels of these retention genes in sorted osteo-
blasts were unchanged 14 h and 7 d after clodronate treatment. 
In addition, the numbers of Nestin+ cells and osteoblasts 14 h 
and 7 d after administration of clodronate were similar to 
Figure 2.  Depletion of mononuclear phagocytes is 
associated with HSC/progenitor mobilization and 
CXCL12 reduction. (A–H) C57BL/6 mice were treated 
with PBS (blue) or clodronate-encapsulated liposomes 
(red). (A) Representative dot plots show the percentages 
of neutrophils, Gr-1hi MOs, Gr-1lo MOs, and M, as de-
scribed in Fig. 1 A. (B–E) Absolute numbers of mono-
nuclear phagocytes and total nucleated cells in the BM  
(n = 11). (F) Absolute numbers of colony-forming units  
in culture in the peripheral blood (CFU-C; n = 12–15).  
(G–H) Enumeration of Lineage Sca-1+ c-kit+ (LSK; G) and 
LSKFlk2 (H) cells in the peripheral blood (n = 9–10).  
B–H represents pooled data from at least three independent 
experiments. (I) RT-PCR analysis of Cxcl12 mRNA levels in 
total BM cells (n = 5 mice per group). Data representative 
of two independent experiments are shown. (J) CXCL12 
levels in the BMEF. Data are pooled from three indepen-
dent experiments.JEM VOL. 208, February 14, 2011 
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Depletion of BM CD169+ M mobilizes  
HSCs/progenitors
The MS-5/M co-culture experiments sug-
gest  that  differentiated  BM  M,  rather  than 
MO,  are  the  mononuclear  phagocytes  that   
promote HSC/progenitor retention. To test di-
rectly whether BM M are promoting HSC/
progenitor retention in the BM, we took ad-
vantage of the differential expression of CD169 
between  MO  and  M  and  mice  expressing 
DTR under the endogenous CD169 promoter (Miyake et al., 
2007). Treatment of heterozygous CD169-DTR mice with 
DT-depleted M (Fig. 5, A and B), but not MO (Fig. 5, A,   
C, and D), in the BM. DT treatment was associated with a 3.5-
fold  increase  in  circulating  hematopoietic  progenitors,  as   
assessed by LSK cell enumeration (Fig. 5 E), and a 5.4-fold 
increase in the stem cell-enriched LSKFlk2 fraction (Fig. 5 F). 
Moreover, depletion of CD169+ M from long-term Dexter 
culture resulted in a 42% reduction in the ability of BM   
stromal cells to produce CXCL12 (Fig. 5 G). Thus, CD169+ 
M in the BM promote stromal production of CXCL12,   
and their specific depletion in vivo is sufficient to mobilize 
HSCs/progenitors.
Parallel and antagonistic roles of M and SNS in regulating 
HSC/progenitor release
The SNS is crucial in HSC/progenitor trafficking (Katayama 
et al., 2006; Méndez-Ferrer et al., 2008) where 3-adrenergic 
receptor (3R) signaling plays a key role in circadian oscilla-
tions of HSC release, and both 2-adrenergic receptor (2R) 
and 3R signaling cooperate in G-CSF–enforced egress 
(Méndez-Ferrer et al., 2010a). M could act independently, 
or alternatively, through alterations in the sympathetic tone. 
Thus, to assess whether M operate through a distinct path-
way, we examined whether clodronate treatment was capable 
of  inducing  mobilization  in  sympathectomized  animals.   
We found that mice chemically sympathectomized with   
6-hydroxydopamine (6OHDA) still exhibited significant pro-
genitor  mobilization  (>7-fold)  in  response  to  clodronate 
Because adherent M appear to interdigitate the stroma 
in Dexter cultures, we sought to determine the relative con-
tribution of M and MO in stromal cell–mediated pro-
genitor retention. Thus, we used the murine stromal cell 
line MS-5 to determine whether the addition of M or 
M-synthesized products could affect the stromal niche. 
MS-5 stromal cells have been used as an appropriate in vitro 
model in which to replicate in vivo modulation of CXCL12 
production by noradrenergic signals (Méndez-Ferrer et al., 2008). 
When grown in medium conditioned by the M cell line 
RAW264.7 (Raschke et al., 1978), CXCL12 production by 
MS-5 was significantly increased (Fig. S7 A), whereas no sig-
nificant difference was observed in medium conditioned by 
the myeloid myeloblast cell line M1 (Ralph et al., 1983;   
Fig. S7B). Co-culture of BM-derived M (BMDM) or media 
conditioned  by  BMDM  increased  MS-5  production  of 
CXCL12, indicating that a secreted soluble factor induces 
CXCL12 up-regulation by MS-5 cells (Fig. 4, D and E).  This 
secreted factor was a protein, as digestion with Proteinase K 
abrogated the ability of M-conditioned medium to raise 
CXCL12 production by M (Fig. 4 F). We have evaluated 
putative candidate factors using antibodies or knockout ani-
mals for IGF-1, IL-1, TNF, or IL-10. However, the loss-of-
function of any one of these factors did not alter the ability of 
BMDM-conditioned medium to induce CXCL12 synthesis 
(Fig. S7, C–F). These data suggest that BM M, through the 
secretion of a yet undefined protein factors, directly promote 
the retention of HSCs/progenitors by raising CXCL12 pro-
duction in BM niche cells.
Figure 3.  Anatomical and functional relationships 
between mononuclear phagocytes and Nestin+ 
niche cells. (A) Distribution of BM CD68+ (white) and 
CD169+ (red) cells in 5-µm femoral sections of Nes-GFP 
mice. Dashed line demarcates separation of bone and 
BM. Images were acquired at 40× magnification (bar,  
20 µm). Isotype control is shown in inset. (B–E) Relative 
expression of Cxcl12 (B), Angpt1 (C), Kitl (D), and Vcam1 
(E) in CD45 Ter119 Nestin+ (Nestin+) and CD45 
Ter119 Nestin (Nestin) fractions sorted from the BM 
and osteoblasts sorted from the bone 14 h after treat-
ment with PBS- (blue bars) or clodronate-encapsulated 
(red bars) liposomes. Data are presented with the mean 
expression of the PBS liposome-treated Nestin+ fraction 
set at 100% and are representative of three indepen-
dent experiments (n = 4–5). Data analyzed by one-way 
ANOVA/Newman-Keuls test. ***, P < 0.001. 266 Bone marrow macrophages promote HSC retention | Chow et al.
began their recovery 
by day 7 after clodro-
nate administration   
(unpublished  data). 
Interestingly,  levels 
of LSK (Fig. 7 B) and LSKFlk2 (Fig. 7 C) inversely matched 
BM M counts. HSCs/progenitors were still elevated in the 
circulation 10 d after clodronate administration (4.2- and 3.2-
fold, respectively), and mobilization persisted at least until day 
16 (Fig. 7 C). These data further support the specific role of 
BM M, but not MO, in promoting the retention of HSCs/
progenitors in the BM.
Because  BM  M  promote  HSC/progenitor  retention, 
we examined whether elimination of this population would 
enhance mobilization using the CXCR4 antagonist AMD3100 
or G-CSF, both of which are clinically approved mobilizing 
agents. We found that clodronate treatment 14 h before harvest 
doubled HSC/progenitor mobilization in AMD3100-treated 
animals and resulted in a significant increase in the number of 
HSCs/progenitors mobilized by G-CSF (Fig. 7, D-E). To further 
assess the role of M in a situation where progenitor mobi-
lization is suboptimal, we treated mice with G-CSF (Hidalgo   
et al., 2004) for 2 d, instead of 4 d. We found that CFU-C, LSK, 
and LSKFlk2 cells in the peripheral blood mobilized by 2 d of 
G-CSF were increased 3.8-, 5.9-, and 9.3-fold (Fig. 7, F-H), 
respectively, in mice that were treated with clodronate lipo-
somes 14 h before harvest. Furthermore, we tested whether 
depleting M 10 d before blood collection, rather than 14 h 
before collection, could synergize with 4 d G-CSF treatment. 
Indeed, when mice were preinfused with clodronate liposomes 
10 d before harvest, they had 5.2-, 3.4-, 2.7- fold higher 
CFU-C, LSK, and LSKFlk2 in the peripheral blood, respec-
tively (Fig. 7, I, J, K). Thus, targeting BM M may be a novel 
modality by which to enhance mobilization yields in patients.
DISCUSSION
In this study, we sought to identify the role of BM mono-
nuclear phagocytes in HSC/progenitor mobilization. Unex-
pectedly, we found that depletion of mononuclear phagocytes 
treatment; however, the absolute number of mobilized pro-
genitors did not reach the level of SNS-intact Clodronate-
treated mice (Fig. 6 A, mid-left bars). To evaluate this issue 
using another model, we used mice deficient in 2R (Adrb2/) 
treated with an antagonist to the 3R. Clodronate treatment 
was still able to cause HSC/progenitor mobilization (>3-fold) 
in these mice, but again HSCs/progenitors did not mobilize 
to the same level as wild type animals (Fig. 6 A, mid-right 
bars). To dissect further the relative contribution of the 2R 
and 3R in SNS promotion of HSC/progenitor release, we 
evaluated the effect of M depletion in mice singly lacking 
2R (Fig. 6 A, right bars) or 3R (Fig. 6 B). Whereas clodro-
nate treatment led to a robust increase in circulating progeni-
tors in Adrb2/ animals compared with wild-type animals 
(Fig. 6 A, right bars), the response was blunted in Adrb3/ 
mice (Fig. 6 B). These data are consistent with previous stud-
ies demonstrating that 3R, but not 2R, signaling is critical 
for physiological HSC/progenitor release (Méndez-Ferrer et al., 
2008). The fact that M depletion can still mobilize HSCs—
albeit at lower amplitude—when SNS signaling is disrupted, 
argues that the SNS and the BM M act through distinct 
parallel pathways. Thus, these data suggest antagonistic func-
tions of the autonomic nervous system and innate immunity 
in regulating the niche (Fig. 6 C), where the SNS promotes 
egress by reducing the expression of key retention factors by 
the niche cell (Méndez-Ferrer et al., 2010b), and in contrast, 
BM M promotes the expression of these genes and HSC/
progenitor retention in the BM.
BM M depletion synergizes with enforced  
HSC/progenitor mobilization
Because the expression of retention genes is still reduced in 
the Nestin+ niche cells 7 d after clodronate treatment (Fig. S5), 
we sought to determine the duration of M reduction and 
the kinetics of recovery. We found that BM M remain 
markedly (>90%) reduced 10 d after clodronate treatment 
(Fig. 7 A). Recovery started by day 16 (58% reduction) and 
clodronate-treated mice demonstrated no reduction in M 
counts by day 28. Alternatively, MO populations in the BM 
Figure 4.   M in culture promote 
CXCL12 production. (A) Morphology of ad-
herent layer of Dexter culture 24 h after addi-
tion of PBS or clodronate liposomes (10×; 
bars, 100 µm). (B) Adherent cells were ana-
lyzed by flow cytometry for CD115+ cells.  
(A and B) Representative data from two inde-
pendent experiments are shown. (C) CXCL12 
levels were assessed by ELISA at 24 h (left 
bars) and 72 h (right bars) after liposomal 
incubation. (D) CXCL12 levels were assessed  
3 d after MS-5 cells were co-cultured with 
(M) or without (Ctrl) BMDM. (E) Levels of 
CXCL12 secreted from MS-5 cells after culture 
with medium conditioned by BMDM (M CM) 
or with control medium (Ctrl). (F) CXCL12 
levels were measured after culture of MS-5 cells 
with control (Ctrl, blue) or M-conditioned 
(M CM, red) medium that was untreated 
(left two bars) or treated with Proteinase  
K (right two bars). (C–F) Representative data 
from at least two independent experiments 
are shown.JEM VOL. 208, February 14, 2011 
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of niche cells that express Nestin (Méndez-Ferrer 
et al., 2010b).
Although osteoblasts have been proposed to 
represent a HSC niche, selective modulation of 
osteoblast numbers do not necessarily alter HSC 
numbers (Wilson and Trumpp, 2006; Kiel et al., 
2007; Zhu et al., 2007), and the lack of osteoblasts 
in sites of extramedullary hematopoiesis suggest 
that they are dispensable to support HSCs. Recent 
studies have suggested that a more primitive pre-
cursor of osteoblasts compose the stem cell niche 
(Méndez-Ferrer et al., 2010b; Omatsu et al., 
2010). Steady-state Nestin+ MSCs express sub-
stantially higher levels of genes required in HSC/
progenitor maintenance and retention, including 
Cxcl12, compared with in vivo sorted (Fig. 3 and 
Fig. S5) or cultured osteoblasts (Méndez-Ferrer et al., 2010b). 
The relatively low expression of Cxcl12 detected in sorted 
osteoblasts  is  consistent  with  a  recent  study  showing  that   
DT administration into Cxcl12-DTR-GFP mice did not   
result in loss of spindle-shaped N-cadherin–expressing osteo-
blasts (Omatsu et al., 
2010).  It  has  been 
proposed  that  M 
depletion  mobilizes 
HSCs/progenitors 
by disruption of the 
using four in vivo models was sufficient to mobilize HSCs/
progenitors. Before this study, mononuclear phagocytes in the 
BM had been poorly characterized and relied on F4/80,   
a marker with a promiscuous expression profile in the BM 
(Fig. S1). Herein, we rigorously discriminated among Gr-1hi 
MOs, Gr1lo MOs, and M in the BM by differential expression 
of  Gr-1,  CD115,  F4/80,  CD11b,  CD11c,  MHC  class  II, 
CX3CR1, CD68, and CD169. Using CD169DTR/+ animals, 
we were able to implicate M, constituting 2.6% of total 
BM cells, in the promotion of HSC/progenitor retention 
through interaction with the recently characterized population 
Figure 5.  Depletion of BM CD169+ M, but  
not CD169 MOs, mobilizes HSCs/progenitors.  
(A–D) Wild-type (WT) or heterozygous CD169-DTR  
(CD169DTR/+) mice were treated with DT. (A) Representa-
tive dot plots show the percentages of BM mononuclear 
phagocytes in wild-type (top) or CD169DTR/+ mice treated 
with DT (bottom). (B–D) Bar graphs depict the absolute 
numbers of mononuclear phagocytes (n = 6) in wild type 
mice and wild type or CD169DTR/+ mice injected with DT. 
(E–F) Bar graphs enumerate Lineage Sca-1+ c-kit+ (LSK; 
E) and LSKFlk2cells (F) per milliliter of blood in the same 
mice analyzed in B–D (n = 6). Data are pooled from two 
independent experiments. (G) CXCL12 levels were mea-
sured 72 h after administration of PBS or 1 µg/ml DT into 
Dexter cultures plated from the BM of CD169-DTR  
animals (n = 3–4 wells). Representative data from two  
independent experiments are shown.
Figure 6.  Opposite influences of the M 
and the SNS on HSC/progenitor retention. 
(A) CFU-C after treatment with PBS (blue 
bars) or clodronate liposomes (red bars) in 
wild-type C57BL/6 (n = 11–13), 6OHDA-
treated mice (n = 12–13), 2-adrenergic re-
ceptor–deficient (Adrb2/) mice treated with 
an antagonist to the 3-adrenergic receptor 
(3R; n = 10), and Adrb2/ mice (n =7).  
Data are pooled from three independent  
experiments and analyzed with one-way 
ANOVA/Newman-Keuls test. (B) CFU-C after 
treatment with PBS (blue bars) or clodronate 
(red bars) in wild-type FVB mice (n = 5) and 
3-adrenergic receptor-deficient (Adrb3/) 
mice (n = 8). Data are pooled from two inde-
pendent experiments. (C) Schematic of an-
tagonistic regulation of HSC/progenitor 
retention by M and the SNS.268 Bone marrow macrophages promote HSC retention | Chow et al.
osteoblasts either 14 h or 7 d after the depletion of M, de-
spite the fact that HSCs/progenitors were clearly elevated at 
both time points. In contrast, significant reductions in the ex-
pression of HSC retention genes were observed in Nestin+ 
cells, and correlated with persistent HSC/progenitor mobili-
zation even 7 d after clodronate treatment. These results thus 
indicate that CD169+ BM M promote HSC retention by 
acting specifically on the Nestin+ HSC niche in the BM.
Previous studies have revealed that a transplantable cell 
expressing  the  G-CSF  receptor  (G-CSFR)  is  essential  for 
G-CSF–induced mobilization (Liu et al., 2000). An accom-
panying study, using an elegant mouse model in which the   
G-CSFR is expressed exclusively in CD68-expressing cells, also 
implicates mononuclear phagocytes in G-CSF mobilization 
(see Christopher et al. in this issue). Thus, G-CSF signaling 
exclusively in M is sufficient to reduce niche retention and 
promote  HSC/progenitor  mobilization.  However,  because 
G-CSF–induced  HSC/progenitor  mobilization  is  at  least 
three times more potent than M depletion with clodronate 
liposomes (this study; Winkler et al., 2010), it must also be 
acting on cells other than M.
The SNS is required for progenitor egress (Katayama et al., 
2006; Méndez-Ferrer et al., 2010a), suggesting that G-CSF–
mediated increase of sympathetic tone in the BM may repre-
sent  a  putative  M-independent  target.  Our  results  using 
models with impaired sympathetic activity suggest that BM 
M exert antagonistic, independent regulatory functions in 
the HSC niche compared with the SNS. Although G-CSF likely 
has several targets in the BM microenvironment, the present data 
uncover two distinct opposing activities that lead to major 
changes in HSC retention by Nestin+ niche cells. We thus 
propose that G-CSF induces HSC mobilization by inhibiting 
M-mediated retention signals and simultaneously enhanc-
ing sympathetic-mediated progenitor release (Fig. 6 C).
These results expand our understanding of HSC niche 
components by implicating a cellular constituent of the innate 
immune system, the CD169+ M, as a niche regulator. Because 
targeted reduction of BM M can enhance HSC/progenitor 
mobilization, the use of antibodies against CSF-1 (M-CSF), 
its receptor, or small molecule inhibitors of M-CSF signaling 
may provide a novel strategy to increase the efficiency of HSC/
progenitor mobilization for autologous transplantation.
MATERIALS AND METHODS
Mice. All experiments, unless otherwise noted, were performed on 8–10-
wk-old C57BL/6 male mice from Charles River Laboratories (Frederick 
Cancer  Research  Center,  Frederick,  Maryland).  2-adrenergic  receptor- 
deficient (Adrb2tm1Bkk/J; Chruscinski et al., 1999; gift from G. Karsenty,   
Columbia University, New York, NY), 3-adrenergic receptor-deficient 
(FVB/N-Adrb3tm1lowl/J; Susulic et al., 1995; The Jackson Laboratory), FVB/
N-CD11b-DTR (Cailhier et al., 2005; gift from C. Aloman, Mount Sinai 
Medical Center, New  York, NY), Mafia (C57BL/6-Tg[Csf1r-EGFP-NGFR/
FKBP1A/TNFRSF6]2Bck/J; Burnett et al., 2004; The Jackson Laboratory), 
CX3CR1/GFP (Jung et al., 2000; gift from D. Littman, New  York University, 
New York, NY), CD169-DTR (Miyake et al., 2007), Nes-Gfp (Mignone   
et al., 2004), Nes-CreERT2 (Balordi and Fishell, 2007), iDTR (C57BL/6-Gt[R
OSA]26Sortm1[HBEGF]Awai/J; Buch et al., 2005), IL-10/ (Berg et al., 1996;   
osteoblastic niche (Winkler et al., 2010). Winkler et al. ob-
served a reduction in osteoblast numbers, as determined by 
histomorphometry, on day 4 after two treatments with clodro-
nate liposomes on days 0 and 2. Although we have not ob-
served any significant reduction in osteoblast counts 14 h 
or 7 d after clodronate treatment, it remains possible that osteo-
blast numbers may have transiently decreased and recovered 
after M ablation. In addition to CXCL12, the regulation   
of other key retention genes appears to correlate with HSC/
progenitor egress. For example, treatment with G-CSF or 3R 
agonists down-regulates Cxcl12, Angiopoietin-1, Kitl, and 
Vcam-1 (Méndez-Ferrer et al., 2010b). We have not detected 
any reductions in the expression of HSC retention genes in 
Figure 7.   M depletion synergizes with AMD3100 and G-CSF  
mobilization. (A–C) Kinetics of M reduction (A) and LSK (B) and LSKFlk2 
(C) mobilization, at the indicated time points, after administration of  
PBS- (blue) or clodronate-encapsulated (red) liposomes (n = 3–4). Data are 
pooled from two independent experiments. (D–E) CFU-C from peripheral 
blood of mice that were treated with PBS (blue) or clodronate liposomes 
(red; 14 h before harvest) and mobilized with AMD3100 (D; 1 h before har-
vest) or G-CSF (E; 4 d). Data are pooled from two independent experiments. 
(F–H) CFU-C (F), LSK (G), and LSKFlk2 (H) cells from the peripheral blood  
of mice that were mobilized for 2 d with G-CSF and treated with PBS- or 
clodronate-encapsulated liposomes 14 h before harvest. Experiment was 
performed once (n = 4). (I–K) CFU-C (I), LSK (J), and LSKFlk2 (K) from  
16-wk-old female mice that were pretreated with PBS- or clodronate-
  encapsulated liposomes 10 d before harvest and mobilized with G-CSF  
for 4 d. Data are representative of two independent experiments (n = 4).JEM VOL. 208, February 14, 2011 
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CFU-C assays and mobilization. Colony-forming assays were performed 
as previously described (Frenette et al., 1998). Mobilization experiments with 
AMD3100 and 4-d G-CSF were performed as previously described (Katayama 
et al., 2006; Lucas et al., 2008). Some experiments were performed with subopti-
mal G-CSF treatment (2 d), as previously described (Hidalgo et al., 2004).
RNA isolation, reverse transcription, and Q-PCR. For measurement 
of BM Cxcl12 gene expression, femurs were flushed and mixed with 0.5 ml 
Trizol (Invitrogen) and stored at 80°C. Conventional reverse transcrip-
tion, using the Sprint PowerScript reverse transcription (Takara Bio Inc.) 
was performed in accordance with the manufacturer’s instructions. Q-PCR 
was performed with SYBR GREEN on an ABI PRISM 7900HT Sequence 
Detection System (Applied Biosystems). The PCR protocol consisted of one 
cycle at 95°C (10 min) followed by 40 cycles of 95°C (15 s) and 60°C   
(1 min). Expression of Gapdh was used as a standard. The mean threshold cycle 
number (Ct) for each tested mRNA was used to quantify the relative ex-
pression of each gene: 2^(Ct[Gapdh]  Ct[gene]). Primers used are listed   
below: Cxcl12_fwd, 5-CGCCAAGGTCGTCGCCG-3; Cxcl12_rev,   
5-TTGGCTCTGGCGATGTGGC-3;  Angpt1_fwd,  5-CTCGTCAG-
ACATTCATCATCCAG-3;  Angpt1_rev,  5-CACCTTCTTTAGTG-
CAAAGGCT-3; Kitl_fwd, 5-CCCTGAAGACTCGGGCCTA-3; Kitl_
rev, 5-CAATTACAAGCGAAATGAGAGCC-3; Vcam1_fwd, 5-GACC-
TGTTCCAGCGAGGGTCTA-3;  Vcam1_rev,  5-CTTCCATCCT-
CATAGCAATTAAGGTG-3;  Osteocalcin_fwd,  5-GGGCAATAAGG-
TAGTGAACAG-3; Osteocalcin_rev, 5-GCAGCACAGGTCCTAAA-
TAGT-3; Gapdh_fwd, 5-TGTGTCCGTCGTGGATCTGA-3; Gapdh_
rev, 5-CCTGCTTCACCACCTTCTTGA-3.
CXCL12 ELISA. 96-well ELISA plates were coated overnight at 4°C with   
50 µl of 2 µg/ml anti-CXCL12 coating antibody (MAB350; R&D Systems). 
Next, the wells were washed three times with wash buffer (0.05% Tween 20 in 
PBS) and incubated for 1 h at room temperature with 200 µl of blocking buffer 
(1% BSA, 5% D-Sucrose, and 0.05% NaN3 in PBS; all from Thermo Fisher Sci-
entific). After 3 washes, 100 µl of samples diluted 1:2 in PBS were added and   
incubated for 2 h at room temperature. After 3 washes, 100 µl of 0.250 µg/ml 
polyclonal biotinylated anti–human/mouse SDF-1 (BAF310; R&D Systems) 
was added and incubated for 2 h at room temperature. After 3 washes, 100 µl of 
0.1 µg/ml Neutravidin-HRP (Thermo Fisher Scientific) was added and incu-
bated for 30 min. After 3 additional washes, the reaction was developed by incu-
bation for 20–30 min with 50 µl of TMB substrate solution (Sigma-Aldrich) and 
stopped by adding 50 µl of 1M HCl solution (Thermo Fisher Scientific). Optical 
density was determined with a microplate reader set at 450 nm. Optical density 
of PBS control wells was subtracted from optical density of samples. Recombi-
nant mSDF-1 (PeproTech) was used to generate a linear standard curve.
Immunofluorescence. Anesthetized Nes-GFP transgenic animals (Mignone 
et al., 2004) were perfused, and femurs and tibia were sectioned and stored as 
previously described (Méndez-Ferrer et al., 2008). Slides were washed three 
times in Coplin jars (Sigma-Aldrich) to remove OCT solution residue, and 
then incubated for 1 h at room temperature in 20% goat serum (Sgma- 
Aldrich) diluted in PBS + 0.1% Tween solution (PBSTw). After 3 washes in 
PBSTw, slides were incubated in PBSTw + 2% goat serum + 0.5% Triton   
X-100 for 1 h at room temperature. After 3 washes in PBSTw, slides were   
incubated in primary antibody (anti-CD68-Alexa Fluor 647 [clone FA-11; 
AbD Serotec] and anti–CD169-biotin [clone MOMA-1; AbCam]) at a 1:100 
concentration in PBSTw + 2% goat serum overnight in the dark at room 
temperature. After three washes in PBSTw, CD169 staining was continued 
with streptavidin-PE staining for 5 min. Slides were mounted with Vector-
shield + DAPI, covered, and sealed with nail polish. Images were acquired   
on an Examiner microscope (Carl Zeiss, Inc.) and all images were processed   
using Slidebook software (Intelligent Imaging Innovations, Inc).
Long-term  BM  Dexter  cultures.  3.7  ×  106  BM-nucleated  cells   
were plated in 1 ml Dexter medium (Myelocult M5300 media [Stem Cell 
Technologies]  supplemented  with  1%  penicillin–streptomycin  [Cellgro],   
gift from H. Xiong, Mount Sinai Medical Center, New York, NY), and 
TNF/ (Marino et al., 1997; gift from M. van den Brink, Memorial Sloan 
Kettering Cancer Center, New  York, NY) mice were also used in these stud-
ies. FVB/N-CD11b-DTR and Mafia (CD45.2) BM chimeras were gener-
ated by transplanting 2.0 × 106 and 1.9 × 106 BM-nucleated cells from male 
donors into lethally irradiated 8-wk-old FVB/N (The Jackson Laboratory) 
and C57BL/6 Ly5.2 (CD45.1) male mice, respectively. BM and blood of 
Mafia BM chimeras showed >95% donor chimerism as assessed by flow cyto-
metry 1 mo after transplantation. Mice were maintained on a 12 h light/ 
12 h darkness lighting schedule. All in vivo experiments were harvested be-
tween 12:00 and 1:00 p.m. (Zeitgeber time 5:00 and 6:00) to limit circadian 
variations in HSC/progenitor release (Méndez-Ferrer et al., 2008) and mo-
bilization (Lucas et al., 2008). All mice were housed in specific pathogen–free 
facilities at the Mount Sinai School of Medicine or Albert Einstein College 
of Medicine animal facility. Experimental procedures performed on the mice 
were approved by the Animal Care and Use Committee of the Mount Sinai 
School of Medicine and Albert Einstein College of Medicine.
In vivo cell depletion. Cl2MDP (or clodronate) was a gift from Roche 
(Van Rooijen and Sanders, 1994). Clodronate liposomes (250 µl) were in-
fused i.v. at 1 d (14 h), 7 d, 10 d, 16 d, or 28 d before harvest. CD11b-DTR 
mice were treated with DT i.p. 25 ng/g on days 1 and 3 before harvest. DT 
was purchased from Sigma-Aldrich. AP20187 was a gift from Ariad Pharma-
ceuticals. Lyophilized AP20187 was dissolved in 100% ethanol at a concentration 
of 62.5 mg/ml stock solution and was stored at –20°C. As recommended   
by Ariad Pharmaceuticals, injection solutions were prepared with a diluent 
composed of 4% ethanol, 10% PEG-400, and 2% Tween-20 in water. All in-
jections were administered i.v. within 30 min after preparation. The volume 
of injection solution was adjusted according to the average mouse body 
weight to deliver a dose of 10 mg/kg AP20187 per mouse in an mean vol-
ume of 100 µl. Mice were injected daily for 5 d before harvest. Heterozygous 
CD169-DTR (CD169DTR/+) or control C57BL/6 were injected i.p. with   
10 µg/kg DT 48 h before harvest. Depletion of Nestin+ cells was accom-
plished as previously described (Méndez-Ferrer et al., 2010b).
Flow cytometry and cell sorting. Fluorochrome-conjugated or biotinylated 
mAbs specific to mouse Gr-1 (Ly6G/C; clone RB6-8C5), CD115 (clone 
AFS98),  Siglec-F  (clone  E50-2440),  CD11b  (clone  M1/70),  CD11c  (clone 
N418), I-A/I-E clone (clone M5/114.15.2), CD45 (clone 30-F11), Sca-1   
(clone D7), Flk2 (clone A2F10), CD117 (clone 2B8), CD3 (clone 145-2C11), 
B220 (clone RA3-6B2), Ter119 (clone TER-119), CD51 (clone RMV-7), and 
CD31 (clone MEC13.3), corresponding isotype controls, and secondary 
reagents (efluor450-, APC-efluor780–, and PE-Cy7–conjugated streptavidin) 
were purchased from eBioscience. Anti-F4/80 (clone CI:A3.1), CD68 (clone 
FA-11), and CD169 (clone 3D6.112) were purchased from AbD Serotec. CD68 
was stained extracellularly and subsequently intracellularly with the Cytofix/
Cytoperm kit (BD) according to the manufacturer’s protocol. Multiparameter 
analyses of stained cell suspensions were performed on an LSRII (BD) and ana-
lyzed with FlowJo software (Tree Star, Inc.). DAPI single cells were evaluated for 
all analyses except for intracellular stains. To purify mononuclear phagocyte pop-
ulations, BM was sorted with an InFlux cell sorter (BD) to achieve >97% purity. 
Sorted mononuclear phagocytes were cytospun with Cytospin 3 (Thermo Fisher 
Scientific) and stained with Hema 3 manual staining system (Thermo Fisher   
Scientific).  To isolate Nestin+ and Nestin cells from the BM for Q-PCR, RBC-
lysed BM cells were digested with collagenase, trypsin, and DNase, as previously 
described (Méndez-Ferrer et al., 2010b). Endothelial cells and osteoblasts were 
isolated similar to previous studies (Semerad et al., 2005; Winkler et al., 2010).   
In brief, tibias, femurs, and humeri of mice were flushed thoroughly of BM   
cells, chopped with a scalpel, and washed three times through a 5-ml polystyrene 
tube with blue-top cell strainer (BD) to further remove residual BM cells. The 
bone fragments were then digested at 37°C with Type IA collagenase (Sigma-
  Aldrich) for 40 min while spinning. RBC-lysed pellet was then stained for sort-
ing. Cells were sorted by Moflo Cell sorter (Dako) at the Flow Cytometry 
Core Facility at Mount Sinai School of Medicine or Aria Cell sorter (BD) at the 
Flow Cytometry Core Facility at Albert Einstein College of Medicine.270 Bone marrow macrophages promote HSC retention | Chow et al.
CXCL12 reduction. Fig. S4 shows the sorting strategy for Nestin+ and Nes-
tin fractions and bone endothelial cell and osteoblast fractions. Fig. S5 shows 
that retention gene expression is reduced in Nestin+ cells seven days after 
mononuclear phagocyte treatment. Fig. S6 shows that mononuclear phago-
cytes are not reduced 7 d after depletion of Nestin+ cells. Fig. S7 shows that 
soluble factor from a M, but not myeloblast, cell line enhances stromal 
CXCL12 production. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20101688/DC1.
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